Applies to nadolol: oral tablets.

Side effects include:

Bradycardia (heart rate <60 bpm), peripheral vascular insufficiency (usually Raynaud’s type), dizziness, fatigue.

For Healthcare Professionals

Applies to nadolol: compounding powder, oral tablet.

General

The most common adverse reactions were bradycardia, cardiac failure, rhythm/conduction disturbances, symptoms of peripheral vascular insufficiency, hypotension, dizziness, and fatigue.^[Ref]

Cardiovascular

Common (1% to 10%): Heart rate less than 60 beats per minute (bpm), heart rate less than 40 bpm, cardiac failure, rhythm/conduction disturbances, symptoms of peripheral vascular insufficiency usually of the Raynaud type, hypotension

Frequency not reported: First degree and third degree heart block, cold extremities^[Ref]

Nervous system

Common (1% to 10%): Dizziness

Uncommon (0.1% to 1%): Paresthesias, sedation, headache, slurred speech, tinnitus

Frequency not reported: Lightheadedness^[Ref]

Other

Common (1% to 10%): Fatigue^[Ref]

Gastrointestinal

Uncommon (0.1% to 1%): Nausea, diarrhea, abdominal discomfort, constipation, vomiting, indigestion, bloating, flatulence, dry mouth^[Ref]

Dermatologic

Uncommon (0.1% to 1%): Rash, pruritus, dry skin, sweating, facial swelling

Frequency not reported: Reversible alopecia^[Ref]

Respiratory

Uncommon (0.1% to 1%): Cough, nasal stuffiness, bronchospasm^[Ref]

Metabolic

Uncommon (0.1% to 1%): Anorexia, weight gain

Frequency not reported: Hypoglycemia^[Ref]

Ocular

Uncommon (0.1% to 1%): Dry eyes, blurred vision^[Ref]

Psychiatric

Uncommon (0.1% to 1%): Change in behavior

Frequency not reported: Insomnia^[Ref]

Genitourinary

Uncommon (0.1% to 1%): Impotence or decreased libido^[Ref]